CYDY Archives

Veru’s (NASDAQ: VERU) Repurposed COVID-19 Drug Facing Uphill Battle for EUA

At first glance Veru, Inc.’s (NASDAQ: VERU) COVID-19 therapy phase 3 top line results were notable but their battle for an emergency...

13

Biotech

CytoDyn (CYDY) Board Starts Anew with Dramatic Cleaning of the Top Leadership

CytoDyn (OTCMKTS: CYDY) investors waking up to the news of the departure of long term CEO and director Nader Pourhassan are probably...

28

1

Biotech

CytoDyn (OTCMKTS: CYDY): A Biotech Under Seige or Preparing for a Counter Attack?

It’s abundantly clear that there is a large short interest in CytoDyn Inc. (OTCMKTS: CYDY). The bear biotech analyst Adam Feuerstein recently...

38

Biotech

Why Todos Medical (OTCMKTS: TOMDF) is Running Ahead of the Pack

Todos Medical (OTCMKTS: TOMDF) was a value play before it started running recently based on sound fundamental analysis, and now investors are...

22

1

Biotech

Picking a Bottom in CytoDyn – Right Now

CytoDyn Inc (OTCMKT: CYDY) has been under considerable selling pressure since April and nothing seems to be able to stop it. In...

9

Biotech

Atea Failure Leaves Todos Medical (TOMDF) Last Man Standing in Oral Antivirals

The big news circulating this week was of Atea Pharmaceuticals’ (NASDAQ: AVIR) COVID-19 antiviral clinical trial failure, which instantly plummeted the stock...

22

Biotech

Moderna’s (MRNA) Bloated Market Cap & mRNA Vaccine Thesis Under Fire

Shares of Moderna (NASDAQ: MRNA) recently spiked over $400, giving the mRNA vaccine maker a market cap of about $200 billion, greater...

23

Biotech

CytoDyn (CYDY) Shorts Throttle Up Bashing Ahead of August Super News Cycle

Short attack timed to capitalize on consolidation and thin trading The Oregonian misquotes and twists statements taken out of context SEC case...

25

2

Biotech

CytoDyn’s Preliminary Phase 1b/2 Cancer Results Likely to Receive Breakthrough Therapy Designation (BTD)

CytoDyn Inc. (OTCMKTS: CYDY) announced excellent preliminary results from its Phase 1b/2 clinical trial in metastatic triple negative breast cancer...